Sort
21,453 grants matching “tuberculosis”
Emerging XDR-TB: Host and Pathogen Contributions
$578,431Gilla Kaplan · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2011 · AI
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
$578,396Eric R Houpt · University Of Virginia · R01 · FY2024 · HL
Mechanisms and regulation of Mycobacterium tuberculosis iron acquisition
$578,299Issar Smith · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2010 · AI
Prevent TB: Application of choice architecture to implement TB preventive therapy in South Africa
$578,215Christopher J Hoffmann · Johns Hopkins University · R01 · FY2020 · AI
Immune and metabolic dysfunction during aging in human cohorts
$578,121Blanca I Restrepo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · AG
Molecular Interactions Of Lymphoid Cell Receptors
$578,096David Margulies · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Pharmacology
$578,064Paul A Volberding · University Of California, San Francisco · P30 · FY2014 · AI
Developmental Core (Core B)
$577,883John Koethe · Vanderbilt University Medical Center · P30 · FY2023 · AI
Th1 Cell Apoptosis in Tuberculosis
$577,812Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2005 · AI
Modeling Epidemic Infectious Diseases Using Sequence Analysis
$577,689Sergei L Kosakovsky Pond · Temple Univ Of The Commonwealth · U01 · FY2017 · GM
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infection
$577,628Robert Owen Watson · Vanderbilt University Medical Center · R01 · FY2025 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$577,586Laura Herrera · Baltimore City Health Department · U52 · FY2009 · PS
Cellular and Bacterial Dynamics in Tuberculosis
$577,349Joel D. Ernst · New York University School Of Medicine · R01 · FY2018 · AI
Cellular and Bacterial Dynamics in Tuberculosis
$577,349Joel D. Ernst · New York University School Of Medicine · R01 · FY2017 · AI
Cellular and Bacterial Dynamics in Tuberculosis
$577,349Joel D. Ernst · New York University School Of Medicine · R01 · FY2016 · AI
BIOCHEMICAL BASIS OF DELAYED TYPE HYPERSENSITIVITY
$577,227Harvard University (Sch Of Public Hlth) · R01 · FY2001 · AI
UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT
$577,198Jeffrey S Stringer · University Of Alabama At Birmingham · U01 · FY2006 · AI
Hotspot versus clinic-based active case finding for TB in Uganda: A pragmatic randomized trial
$576,980Emily A Kendall · Johns Hopkins University · R01 · FY2025 · HL
Molecular pathogenesis of Blastomycosis
$576,980Bruce Steven Klein · University Of Wisconsin-Madison · R01 · FY2016 · AI
Biomarkers and Signaling in Tuberculosis
$576,862William Ramses Bishai · Johns Hopkins University · R01 · FY2013 · AI
Short course combination regimens for treatment of Mycobacterium avium pulmonary disease: a translational bench-to-bedside approach
$576,660Shashi Kant · University Of Texas Hlth Ctr At Tyler · R01 · FY2024 · AI
Host-Pathogen Interactions in a Failing Global lineage of MTBC:M.africanum
$576,528Souleymane Diallo · Univ Of Sciences, Tech & Tech Of Bamako · R01 · FY2014 · AI
Studies of lipoamide dehydrogenase tight binding inhibition in tuberculous and non-tuberculous mycobacteria
$576,414Ruslana Bryk · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Molecular Genetic Analysis of Mycobacterium tuberculosis
$576,342William Robert Jacobs · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
Molecular Genetic Analysis of Mycobacterium tuberculosis
$576,342William Robert Jacobs · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · AI